Clinical Trials Browser

Completed × INDUSTRY × Solid Tumor × Clear all

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05735366 2026-03-10

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04175847 2026-01-07

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05174585 2026-01-06

JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT05991349 2025-11-25

A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT05109832 2025-09-16

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05390944 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05391048 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03195478 2025-09-15

A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors

Phase 1/2 Completed

37 enrolled 32 charts

Other solid neoplasm

Solid Tumor

NCT04937153 2025-07-16

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05323045 2025-07-09

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07030439 2025-06-22

A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07019194 2025-06-13

An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03517917 2025-05-23

Prospective Tissue Collection Research Protocol

Other solid neoplasm

Solid Tumor

NCT04720976 2025-04-11

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT02454010 2025-04-04

A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01585623 2025-03-05

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06258330 2025-01-28

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05176509 2025-01-06

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357820 2024-11-21

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357911 2024-11-21

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT04366648 2024-09-04

Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05088070 2024-08-30

Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04410224 2024-07-10

ASN004

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04403308 2024-05-03

ONO-7913 Phase I Study (ONO-7913)

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00921336 2024-04-25

Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05173792 2024-04-25

Study of AK119 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03861156 2024-04-09

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

Phase 2 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT04557306 2024-04-08

Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05547906 2024-03-13

Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05248074 2024-02-20

To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04862767 2024-01-31

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04235101 2024-01-05

Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04475523 2023-10-27

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03099109 2023-10-17

A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor

NCT04346381 2023-09-18

Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT03834948 2023-08-22

AO-176 in Multiple Solid Tumor Malignancies

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT02959619 2023-08-21

Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Phase 1 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT03990454 2023-08-18

Safety Study of SLC-391 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05119998 2023-08-18

A Phase I Study of IBI325 in Patients With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05898451 2023-06-12

R-2

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT05046808 2023-06-08

Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05336279 2023-05-18

Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05126927 2023-04-12

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT02278250 2023-03-16

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Phase 1 Completed

97 enrolled 77 charts

Other solid neoplasm

Solid Tumor

NCT04547205 2023-02-23

A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05230290 2023-02-06

Clinical Study of KD6001 in Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor